Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]

Background: The Malawi-Liverpool Wellcome Trust Clinical Research Programme (MLW) has undertaken sentinel surveillance of bloodstream infection and meningitis at Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi for 20 years. Previously, three epidemics of Salmonella bloodstream infection ha...

Full description

Bibliographic Details
Main Authors: Heather Galloway, Nicholas A. Feasey, Brigitte Denis, Melita Gordon, Clemens Masesa, Catherine N. Wilson, Angeziwa Chunga, Sithembile Bilima, Niza Silungwe
Format: Article
Language:English
Published: Wellcome 2022-04-01
Series:Wellcome Open Research
Subjects:
Online Access:https://wellcomeopenresearch.org/articles/7-143/v1
_version_ 1797833214124883968
author Heather Galloway
Nicholas A. Feasey
Brigitte Denis
Melita Gordon
Clemens Masesa
Catherine N. Wilson
Angeziwa Chunga
Sithembile Bilima
Niza Silungwe
author_facet Heather Galloway
Nicholas A. Feasey
Brigitte Denis
Melita Gordon
Clemens Masesa
Catherine N. Wilson
Angeziwa Chunga
Sithembile Bilima
Niza Silungwe
author_sort Heather Galloway
collection DOAJ
description Background: The Malawi-Liverpool Wellcome Trust Clinical Research Programme (MLW) has undertaken sentinel surveillance of bloodstream infection and meningitis at Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi for 20 years. Previously, three epidemics of Salmonella bloodstream infection have been identified. Here we provide updated surveillance data on invasive non-typhoidal Salmonella disease from 2011 – 2019. Methods: Surveillance data describing trends in invasive non-typhoidal Salmonella disease and associated antimicrobial susceptibility profiles are presented for the period January 2011 – December 2019. Results: Between January 2011-December 2019, 128,588 blood cultures and 40,769 cerebrospinal fluid cultures were processed at MLW. Overall, 1.00% of these were positive for S. Typhimurium, 0.10% for S. Enteritidis, and 0.05% positive for other Salmonella species. Estimated minimum incidence of invasive non-typhoidal Salmonella (iNTS) disease decreased from 21/100,000 per year in 2011 to 7/100,000 per year in 2019. Over this period, 26 confirmed cases of Salmonella meningitis were recorded (88.5% S. Typhimurium). Between 2011-2019 there was a substantial decrease in proportion of S. Typhimurium (78.5% to 27.7%) and S. Enteritidis (31.8% in 2011 to 0%) that were multidrug-resistant. Resistance to fluoroquinolones and third-generation generation cephalosporins (3GC) remained uncommon, however 3GC increased amongst Salmonella spp. and S. Typhimurium in the latter part of the period. Conclusions: The total number of iNTS bloodstream infections decreased between 2011-2019. Although the number multidrug resistance (MDR) S. Typhimurium and S. Enteritidis isolates has fallen, the number of MDR isolates of other Salmonella spp. has increased, including 3GC isolates.
first_indexed 2024-04-09T14:19:44Z
format Article
id doaj.art-929c7de0dce64e68a33e73060760194c
institution Directory Open Access Journal
issn 2398-502X
language English
last_indexed 2024-04-09T14:19:44Z
publishDate 2022-04-01
publisher Wellcome
record_format Article
series Wellcome Open Research
spelling doaj.art-929c7de0dce64e68a33e73060760194c2023-05-05T01:00:00ZengWellcomeWellcome Open Research2398-502X2022-04-01719650Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]Heather Galloway0Nicholas A. Feasey1https://orcid.org/0000-0003-4041-1405Brigitte Denis2Melita Gordon3https://orcid.org/0000-0002-0629-0884Clemens Masesa4Catherine N. Wilson5https://orcid.org/0000-0002-7150-3081Angeziwa Chunga6https://orcid.org/0000-0001-6500-2902Sithembile Bilima7Niza Silungwe8Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UKMalawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, MalawiMalawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, MalawiInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L69 3BX, UKMalawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, MalawiInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L69 3BX, UKInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L69 3BX, UKMalawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, MalawiMalawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, MalawiBackground: The Malawi-Liverpool Wellcome Trust Clinical Research Programme (MLW) has undertaken sentinel surveillance of bloodstream infection and meningitis at Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi for 20 years. Previously, three epidemics of Salmonella bloodstream infection have been identified. Here we provide updated surveillance data on invasive non-typhoidal Salmonella disease from 2011 – 2019. Methods: Surveillance data describing trends in invasive non-typhoidal Salmonella disease and associated antimicrobial susceptibility profiles are presented for the period January 2011 – December 2019. Results: Between January 2011-December 2019, 128,588 blood cultures and 40,769 cerebrospinal fluid cultures were processed at MLW. Overall, 1.00% of these were positive for S. Typhimurium, 0.10% for S. Enteritidis, and 0.05% positive for other Salmonella species. Estimated minimum incidence of invasive non-typhoidal Salmonella (iNTS) disease decreased from 21/100,000 per year in 2011 to 7/100,000 per year in 2019. Over this period, 26 confirmed cases of Salmonella meningitis were recorded (88.5% S. Typhimurium). Between 2011-2019 there was a substantial decrease in proportion of S. Typhimurium (78.5% to 27.7%) and S. Enteritidis (31.8% in 2011 to 0%) that were multidrug-resistant. Resistance to fluoroquinolones and third-generation generation cephalosporins (3GC) remained uncommon, however 3GC increased amongst Salmonella spp. and S. Typhimurium in the latter part of the period. Conclusions: The total number of iNTS bloodstream infections decreased between 2011-2019. Although the number multidrug resistance (MDR) S. Typhimurium and S. Enteritidis isolates has fallen, the number of MDR isolates of other Salmonella spp. has increased, including 3GC isolates.https://wellcomeopenresearch.org/articles/7-143/v1Salmonella infection bloodstream surveillance antimicrobial resistanceeng
spellingShingle Heather Galloway
Nicholas A. Feasey
Brigitte Denis
Melita Gordon
Clemens Masesa
Catherine N. Wilson
Angeziwa Chunga
Sithembile Bilima
Niza Silungwe
Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]
Wellcome Open Research
Salmonella
infection
bloodstream
surveillance
antimicrobial resistance
eng
title Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]
title_full Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]
title_fullStr Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]
title_full_unstemmed Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]
title_short Incidence of invasive non-typhoidal Salmonella in Blantyre, Malawi between January 2011-December 2019 [version 1; peer review: 2 approved]
title_sort incidence of invasive non typhoidal salmonella in blantyre malawi between january 2011 december 2019 version 1 peer review 2 approved
topic Salmonella
infection
bloodstream
surveillance
antimicrobial resistance
eng
url https://wellcomeopenresearch.org/articles/7-143/v1
work_keys_str_mv AT heathergalloway incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT nicholasafeasey incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT brigittedenis incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT melitagordon incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT clemensmasesa incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT catherinenwilson incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT angeziwachunga incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT sithembilebilima incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved
AT nizasilungwe incidenceofinvasivenontyphoidalsalmonellainblantyremalawibetweenjanuary2011december2019version1peerreview2approved